Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CGON compared with AKTS: revenue, margins and what each company keeps, and the suppliers and customers both name
CGON
CG Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
AKTS
Aktis Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CGON
CG Oncology, Inc.
vs
AKTS
Aktis Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: CGON, AKTS.
Role chip = supplier or customer
Source: SEC EDGAR
CGON
CG Oncology, Inc.
Change
75.60
▲
+16.67%
· post 76.50
Mkt cap
$6.8B
Revenue
$2M
Q3 FY26
AKTS
Aktis Oncology, Inc.
Change
15.87
▲
+6.88%
· post 15.87
Closed
Nov 6 '26
Mkt cap
$874.8M
Revenue
$3M
Q2 FY26
vs
Compare
Closed
Nov 6 '26
CGON
CG Oncology, Inc.
vs
AKTS
Aktis Oncology, Inc.
75.60
▲
+16.67%
post 76.50
Price
15.87
▲
+6.88%
post 15.87
$6.8B
Mkt cap
$874.8M
Q3 FY26
$2M
Revenue
$3M
Q2 FY26
Change
Change
CGON
75.60
▲
+16.67%
vs
AKTS
15.87
▲
+6.88%
Closed
Nov 6 '26